Vimarsana
Biggest News Aggregation in the World

Page 2 - Asserted Claims News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asserted Claims. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asserted Claims Today - Breaking & Trending Today

Judge Albright Grants Defendant Lyft, Inc.'s Motion To Dismiss For Improper Venue Under FRCP 12(b)(3) - Patent - Vimarsana News

Judge Albright Grants Defendant Lyft, Inc.'s Motion To Dismiss For Improper Venue Under FRCP 12(b)(3) - Patent

Judge Albright dismissed Plaintiff Fare Technologies LLC's complaint against Lyft, Inc. for failure to plead that Defendant has a server in W.D. Tex. that could comprise the "computer" of the asserted...

Source: mondaq.com
Lilly's CIALIS patent claims extending to "physiologically acceptable salt" found invalid for overbreadth and insufficiency | Smart & Biggar - Vimarsana News

Lilly's CIALIS patent claims extending to "physiologically acceptable salt" found invalid for overbreadth and insufficiency | Smart & Biggar

On October 17, 2022, Justice St-Louis of the Federal Court granted a motion for summary trial brought by Teva, Pharmascience, Laboratoire Riva, Apotex and Mylan (the Defendants) and...

Federal Court finds Janssen's macitentan combination therapy patent valid | Smart & Biggar - Vimarsana News

Federal Court finds Janssen's macitentan combination therapy patent valid | Smart & Biggar

On May 31, 2022, the Federal Court released a decision by Justice Pallotta in a patent infringement action pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance)...

Out Of The ITC In 100 Days - Patent - United States - Vimarsana News

Out Of The ITC In 100 Days - Patent - United States

A few months ago, we explored ideas for defendants who wished to quickly dispense with lawsuits involving patents directed to patent ineligible subject matter like abstract ideas or laws of nature.

Source: mondaq.com
Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo - Vimarsana News

Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo

- Jury Upholds Validity of Asserted Claims of the Patent, Finds Willful Infringement and Issues Past Damages Award of $41.82 Million -- Seagen to Request Royalty on Future U.S. Sales of Enhertu® Through the Life of the Patent -- Separate Arbitration Proceedings with Daiichi Sankyo Remain Ongoing with a Decision Expe...